Casula M.; Galimberti F.; Iommi M.; Olmastroni E.; Rosa S.; Altini M.; Catapano A.L.; Tragni E.; Poluzzi E., Impact of the COVID-19 Pandemic on the Therapeutic Continuity among Outpatients with Chronic Cardiovascular Therapies, «INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH», 2022, 19, Article number: 12101 , pp. 1 - 11 [Scientific article]Open Access
Fusaroli M.; Raschi E.; Giunchi V.; Menchetti M.; Rimondini Giorgini R.; De Ponti F.; Poluzzi E., Impulse Control Disorders by Dopamine Partial Agonists: A Pharmacovigilance-Pharmacodynamic Assessment Through the FDA Adverse Event Reporting System, «INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY», 2022, 25, pp. 727 - 736 [Scientific article]Open Access
Raschi, Emanuel; Fusaroli, Michele; Gatti, Milo; Caraceni, Paolo; Poluzzi, Elisabetta; De Ponti, Fabrizio, Liver Injury with Nintedanib: A Pharmacovigilance-Pharmacokinetic Appraisal, «PHARMACEUTICALS», 2022, 15, Article number: 645 , pp. 1 - 11 [Scientific article]Open Access
Zazzara M.B.; Cangini A.; Da Cas R.; Ippoliti I.; Marengoni A.; Pierantozzi A.; Poluzzi E.; Zito S.; Onder G., Medication Use and Costs Among Older Adults Aged 90 Years and Older in Italy, «FRONTIERS IN PHARMACOLOGY», 2022, 13, Article number: 818875 , pp. 1 - 7 [Scientific article]Open Access
Fusaroli M.; Isgro V.; Cutroneo P.M.; Ferrajolo C.; Cirillo V.; Del Bufalo F.; Raschi E.; Poluzzi E.; Trifiro G., Post-Marketing Surveillance of CAR-T-Cell Therapies: Analysis of the FDA Adverse Event Reporting System (FAERS) Database, «DRUG SAFETY», 2022, 45, pp. 891 - 908 [Scientific article]Open Access
Giunchi, V; Fusaroli, M; Lunghi, C; Zongo, A; Raschi, E; Poluzzi, E, Post-marketing safety profile of cannabis products: Signals from the FDA adverse event reporting system, «PHARMACOEPIDEMIOLOGY AND DRUG SAFETY», 2022, 31, pp. 222 - 223 [Abstract]
Raschi, Emanuel; Poluzzi, Elisabetta; Ponti, Fabrizio De, QT prolongation with anticancer drugs: a multimodal issue, «THE LANCET ONCOLOGY», 2022, 23, pp. 522 - 522 [Comment or similar]
Di Valerio, Zeno; La Fauci, Giusy; Soldà, Giorgia; Montalti, Marco; Lenzi, Jacopo; Forcellini, Marcello; Barvas, Edoardo; Guttmann, Susanna; Poluzzi, Elisabetta; Raschi, Emanuel; Riccardi, Rossano; Fantini, Maria Pia; Salussolia, Aurelia; Gori, Davide, ROCCA cohort study: Nationwide results on safety of Gam-COVID-Vac vaccine (Sputnik V) in the Republic of San Marino using active surveillance, «ECLINICALMEDICINE», 2022, 49, Article number: 101468 , pp. 1 - 11 [Scientific article]Open Access
Raschi, E.; Fusaroli, M.; La Placa, M.; Ardizzoni, A.; Zamagni, C.; Poluzzi, E.; De Ponti, F., Skin Toxicities with Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: Signals from Disproportionality Analysis of the FDA Adverse Event Reporting System, «AMERICAN JOURNAL OF CLINICAL DERMATOLOGY», 2022, 23, pp. 247 - 255 [Scientific article]
Lunghi C.; Trevisan C.; Fusaroli M.; Giunchi V.; Raschi E.; Sangiorgi E.; Domenicali M.; Volpato S.; De Ponti F.; Poluzzi E., Strategies and Tools for Supporting the Appropriateness of Drug Use in Older People, «PHARMACEUTICALS», 2022, 15, Article number: 977 , pp. 1 - 15 [Scientific article]Open Access
Raschi E.; Fusaroli M.; Massari F.; Mollica V.; Repaci A.; Ardizzoni A.; Poluzzi E.; Pagotto U.; Di Dalmazi G., The Changing Face of Drug-induced Adrenal Insufficiency in the Food and Drug Administration Adverse Event Reporting System, «THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM», 2022, 107, pp. 3107 - 3114 [Scientific article]Open Access
Roberto G.; Girardi A.; Barone-Adesi F.; Pecere A.; Ientile V.; Bartolini C.; Da Cas R.; Spila-Alegiani S.; Ferrajolo C.; Francesconi P.; Trifiro G.; Poluzzi E.; Baccetti F.; Gini R., Time to Treatment Intensification in Patients Receiving DPP4 Inhibitors Versus Sulfonylureas as the First Add-On to Metformin Monotherapy: A Retrospective Cohort Study, «FRONTIERS IN PHARMACOLOGY», 2022, 13, Article number: 871052 , pp. 1 - 10 [Scientific article]Open Access
Galai E.; Scotti L.; Gilardetti M.; Ucciero A.; Ferrante D.; Poluzzi E.; Genazzani A.A.; Barone-Adesi F., Time-Trends of Drug-Drug Interactions among Elderly Outpatients in the Piedmont Region (Italy): A Population-Based Study, «INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH», 2022, 19, Article number: 7353 , pp. 1 - 10 [Scientific article]Open Access
Lunghi, C; Fusaroli, M; Giunchi, V; Raschi, E; Zongo, A; Poluzzi, E, What Is the Safety Profile of Cannabis-Based Medications? Analysis of the Post-Marketing Signals from the FDA Adverse Event Reporting System, «DRUG SAFETY», 2022, 45, pp. 1242 - 1243 [Abstract]
Baldin E.; Zenesini C.; Antonazzo I.C.; Bartolomei I.; Caniatti L.; Costa M.; Curti E.; Ferraro D.; Foschi M.; Granella F.; Guareschi A.; Immovilli P.; Lugaresi A.; Malagu S.; Mancinelli L.; Montepietra S.; Mussuto V.; Neri W.; Pasquinelli M.; Pellegrino L.; Pesci I.; Poluzzi E.; Pugliatti M.; Ravasio A.; Riise T.; Salvi F.; Santangelo M.; Sireci F.; Sola P.; Strumia S.; Tsantes E.; Vignatelli L.; Vitetta F.; Viti B.; D'Alessandro R., Antibiotic Use and Risk of Multiple Sclerosis: A Nested Case-Control Study in Emilia-Romagna Region, Italy, «NEUROEPIDEMIOLOGY», 2021, 55, pp. 224 - 231 [Scientific article]
